Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
MBLY Quote, Financials, Valuation and Earnings
Last price:
$16.27
Seasonality move
:
-26.76%
Day range:
$15.58 - $16.35
52-week range:
$10.48 - $27.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.93x
P/B ratio:
1.07x
Volume:
8.5M
Avg. volume:
6.9M
1-year change:
-41.27%
Market cap:
$12.9B
Revenue:
$1.7B
EPS (TTM):
-$3.68
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $967M | $1.4B | $1.9B | $2.1B | $1.7B | |
| Revenue Growth (YoY) | 10.01% | 43.33% | 34.85% | 11.24% | -20.44% | |
| Cost of Revenues | $591M | $731M | $947M | $1B | $913M | |
| Gross Profit | $376M | $655M | $922M | $1B | $741M | |
| Gross Profit Margin | 38.88% | 47.26% | 49.33% | 50.36% | 44.8% | |
| R&D Expenses | $440M | $544M | $789M | $889M | $1.1B | |
| Selling, General & Admin | $149M | $168M | $170M | $191M | $188M | |
| Other Inc / (Exp) | -$5M | -- | -- | -- | -$2.7B | |
| Operating Expenses | $589M | $712M | $959M | $1.1B | $1.3B | |
| Operating Income | -$213M | -$57M | -$37M | -$33M | -$530M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$212M | -$57M | -$32M | $16M | -$3.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$16M | $18M | $50M | $43M | -$73M | |
| Net Income to Company | -$196M | -$75M | -$82M | -$27M | -$3.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$196M | -$75M | -$82M | -$27M | -$3.1B | |
| Basic EPS (Cont. Ops) | -$0.25 | -$0.09 | -$0.11 | -$0.03 | -$3.82 | |
| Diluted EPS (Cont. Ops) | -$0.25 | -$0.09 | -$0.11 | -$0.03 | -$3.82 | |
| Weighted Average Basic Share | $795.8M | $795.8M | $759M | $805M | $809M | |
| Weighted Average Diluted Share | $795.8M | $795.8M | $759M | $805M | $809M | |
| EBITDA | $251M | $469M | $559M | $529M | -$2.7B | |
| EBIT | -$212M | -$57M | -$8M | $16M | -$3.2B | |
| Revenue (Reported) | $967M | $1.4B | $1.9B | $2.1B | $1.7B | |
| Operating Income (Reported) | -$213M | -$57M | -$37M | -$33M | -$530M | |
| Operating Income (Adjusted) | -$212M | -$57M | -$8M | $16M | -$3.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $394M | $458M | $239M | $438M | |
| Revenue Growth (YoY) | -- | -- | 16.24% | -47.82% | 83.26% | |
| Cost of Revenues | -- | $218M | $251M | $185M | $231M | |
| Gross Profit | -- | $176M | $207M | $54M | $207M | |
| Gross Profit Margin | -- | 44.67% | 45.2% | 22.59% | 47.26% | |
| R&D Expenses | -- | $180M | $235M | $243M | $275M | |
| Selling, General & Admin | -- | $42M | $53M | $49M | $49M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | $222M | $288M | $292M | $324M | |
| Operating Income | -- | -$46M | -$81M | -$238M | -$117M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$44M | -$73M | -$221M | -$99M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $16M | $6M | -$3M | $3M | |
| Net Income to Company | -- | -$60M | -$79M | -$218M | -$102M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$60M | -$79M | -$218M | -$102M | |
| Basic EPS (Cont. Ops) | -- | -$0.08 | -$0.10 | -$0.27 | -$0.13 | |
| Diluted EPS (Cont. Ops) | -- | -$0.08 | -$0.10 | -$0.27 | -$0.13 | |
| Weighted Average Basic Share | -- | $795.8M | $802M | $806M | $812M | |
| Weighted Average Diluted Share | -- | $795.8M | $802M | $806M | $812M | |
| EBITDA | -- | $108M | $59M | -$113M | $12M | |
| EBIT | -- | -$46M | -$81M | -$238M | -$117M | |
| Revenue (Reported) | -- | $394M | $458M | $239M | $438M | |
| Operating Income (Reported) | -- | -$46M | -$81M | -$238M | -$117M | |
| Operating Income (Adjusted) | -- | -$46M | -$81M | -$238M | -$117M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.9B | $1.9B | $1.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $980M | $966M | $959M | |
| Gross Profit | -- | -- | $953M | $894M | $894M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $844M | $897M | $1.1B | |
| Selling, General & Admin | -- | -- | $181M | $187M | $188M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$2.7B | |
| Operating Expenses | -- | -- | $1B | $1.1B | $1.3B | |
| Operating Income | -- | -- | -$72M | -$190M | -$409M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$61M | -$132M | -$3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $40M | $34M | -$67M | |
| Net Income to Company | -- | -- | -$101M | -$166M | -$3B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$101M | -$166M | -$3B | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.13 | -$0.21 | -$3.68 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.13 | -$0.21 | -$3.68 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | $508M | $357M | -$2.5B | |
| EBIT | -- | -- | -$45M | -$141M | -$3B | |
| Revenue (Reported) | -- | -- | $1.9B | $1.9B | $1.9B | |
| Operating Income (Reported) | -- | -- | -$72M | -$190M | -$409M | |
| Operating Income (Adjusted) | -- | -- | -$45M | -$141M | -$3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $394M | $458M | $239M | $438M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $218M | $251M | $185M | $231M | |
| Gross Profit | -- | $176M | $207M | $54M | $207M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $180M | $235M | $243M | $275M | |
| Selling, General & Admin | -- | $42M | $53M | $49M | $49M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | $222M | $288M | $292M | $324M | |
| Operating Income | -- | -$46M | -$81M | -$238M | -$117M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$44M | -$73M | -$221M | -$99M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $16M | $6M | -$3M | $3M | |
| Net Income to Company | -- | -$60M | -$79M | -$218M | -$102M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$60M | -$79M | -$218M | -$102M | |
| Basic EPS (Cont. Ops) | -- | -$0.08 | -$0.10 | -$0.27 | -$0.13 | |
| Diluted EPS (Cont. Ops) | -- | -$0.08 | -$0.10 | -$0.27 | -$0.13 | |
| Weighted Average Basic Share | -- | $795.8M | $802M | $806M | $812M | |
| Weighted Average Diluted Share | -- | $795.8M | $802M | $806M | $812M | |
| EBITDA | -- | $108M | $59M | -$113M | $12M | |
| EBIT | -- | -$46M | -$81M | -$238M | -$117M | |
| Revenue (Reported) | -- | $394M | $458M | $239M | $438M | |
| Operating Income (Reported) | -- | -$46M | -$81M | -$238M | -$117M | |
| Operating Income (Adjusted) | -- | -$46M | -$81M | -$238M | -$117M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $85M | $616M | $1B | $1.2B | $1.4B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $93M | $155M | $269M | $357M | $212M | |
| Inventory | $128M | $97M | $113M | $391M | $415M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $54M | $76M | $110M | $106M | $121M | |
| Total Current Assets | $1.7B | $2.3B | $1.5B | $2.1B | $2.2B | |
| Property Plant And Equipment | $187M | $304M | $384M | $447M | $458M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $10.9B | $10.9B | $10.9B | $10.9B | $8.2B | |
| Other Intangibles | $3.6B | $3.1B | $2.5B | $2.1B | $1.6B | |
| Other Long-Term Assets | $108M | $115M | $119M | $116M | $138M | |
| Total Assets | $16.5B | $16.7B | $15.4B | $15.6B | $12.6B | |
| Accounts Payable | $109M | $160M | $189M | $229M | $190M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $27M | $49M | $34M | $48M | $34M | |
| Total Current Liabilities | $310M | $474M | $384M | $403M | $333M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $620M | $766M | $647M | $653M | $492M | |
| Common Stock | $15.8B | $15.9B | $9M | $8M | $8M | |
| Other Common Equity Adj | -- | $5M | -$9M | -- | $2M | |
| Common Equity | $15.8B | $15.9B | $14.8B | $14.9B | $12.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $15.8B | $15.9B | $14.8B | $14.9B | $12.1B | |
| Total Liabilities and Equity | $16.5B | $16.7B | $15.4B | $15.6B | $12.6B | |
| Cash and Short Terms | $85M | $616M | $1B | $1.2B | $1.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $1.2B | $1.2B | $1.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $239M | $120M | $217M | |
| Inventory | -- | -- | $173M | $456M | $364M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $82M | $132M | $122M | |
| Total Current Assets | -- | -- | $1.7B | $1.9B | $2.2B | |
| Property Plant And Equipment | -- | -- | $401M | $454M | $450M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | $10.9B | $10.9B | $8.2B | |
| Other Intangibles | -- | -- | $2.4B | $1.9B | $1.5B | |
| Other Long-Term Assets | -- | -- | $117M | $120M | $135M | |
| Total Assets | -- | -- | $15.5B | $15.3B | $12.5B | |
| Accounts Payable | -- | -- | $208M | $166M | $150M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $36M | $33M | $31M | |
| Total Current Liabilities | -- | -- | $418M | $329M | $290M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $675M | $579M | $449M | |
| Common Stock | -- | -- | $9M | $8M | $8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -$1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $14.8B | $14.8B | $12B | |
| Total Liabilities and Equity | -- | -- | $15.5B | $15.3B | $12.5B | |
| Cash and Short Terms | -- | -- | $1.2B | $1.2B | $1.5B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$196M | -$75M | -$82M | -$27M | -$3.1B | |
| Depreciation & Amoritzation | $463M | $526M | $567M | $513M | $506M | |
| Stock-Based Compensation | $85M | $97M | $174M | $252M | $279M | |
| Change in Accounts Receivable | $7M | -$62M | -$114M | -$88M | $124M | |
| Change in Inventories | -$25M | $31M | -$16M | -$278M | -$24M | |
| Cash From Operations | $271M | $599M | $546M | $394M | $400M | |
| Capital Expenditures | $91M | $143M | $111M | $98M | $81M | |
| Cash Acquisitions | -$745M | -- | -- | -- | -- | |
| Cash From Investing | -$965M | -$157M | $1.2B | -$98M | -$120M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$337M | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $732M | $91M | -$2B | -$100M | -$66M | |
| Cash From Financing | $732M | $91M | -$1.3B | -$100M | -$66M | |
| Beginning Cash (CF) | $55M | $93M | $625M | $1B | $1.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $38M | $533M | $416M | $196M | $214M | |
| Ending Cash (CF) | $93M | $625M | $1B | $1.2B | $1.4B | |
| Levered Free Cash Flow | $180M | $456M | $435M | $296M | $319M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$60M | -$79M | -$218M | -$102M | |
| Depreciation & Amoritzation | -- | $154M | $140M | $125M | $129M | |
| Stock-Based Compensation | -- | $40M | $72M | $62M | $65M | |
| Change in Accounts Receivable | -- | -$30M | $30M | $216M | -$5M | |
| Change in Inventories | -- | -$13M | -$60M | -$65M | $51M | |
| Cash From Operations | -- | $51M | $171M | $40M | $109M | |
| Capital Expenditures | -- | $27M | $26M | $22M | $14M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | $173M | -$26M | -$22M | -$25M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$91M | -$3M | -$4M | $3M | |
| Cash From Financing | -- | -$91M | -$3M | -$4M | $3M | |
| Beginning Cash (CF) | -- | $625M | $1B | $1.2B | $1.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -$4M | -$2M | $2M | |
| Additions / Reductions | -- | $133M | $142M | $14M | $87M | |
| Ending Cash (CF) | -- | $758M | $1.2B | $1.2B | $1.5B | |
| Levered Free Cash Flow | -- | $24M | $145M | $18M | $95M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$101M | -$166M | -$3B | |
| Depreciation & Amoritzation | -- | -- | $553M | $498M | $510M | |
| Stock-Based Compensation | -- | $40M | $206M | $242M | $282M | |
| Change in Accounts Receivable | -- | -- | -$54M | $98M | -$97M | |
| Change in Inventories | -- | -- | -$63M | -$283M | $92M | |
| Cash From Operations | -- | -- | $666M | $263M | $469M | |
| Capital Expenditures | -- | $27M | $110M | $94M | $73M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | $988M | -$94M | -$123M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$337M | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$1.9B | -$101M | -$59M | |
| Cash From Financing | -- | -- | -$1.2B | -$101M | -$59M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $425M | $68M | $287M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | $556M | $169M | $396M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$60M | -$79M | -$218M | -$102M | |
| Depreciation & Amoritzation | -- | $154M | $140M | $125M | $129M | |
| Stock-Based Compensation | -- | $40M | $72M | $62M | $65M | |
| Change in Accounts Receivable | -- | -$30M | $30M | $216M | -$5M | |
| Change in Inventories | -- | -$13M | -$60M | -$65M | $51M | |
| Cash From Operations | -- | $51M | $171M | $40M | $109M | |
| Capital Expenditures | -- | $27M | $26M | $22M | $14M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | $173M | -$26M | -$22M | -$25M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$91M | -$3M | -$4M | $3M | |
| Cash From Financing | -- | -$91M | -$3M | -$4M | $3M | |
| Beginning Cash (CF) | -- | $625M | $1B | $1.2B | $1.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -$4M | -$2M | $2M | |
| Additions / Reductions | -- | $133M | $142M | $14M | $87M | |
| Ending Cash (CF) | -- | $758M | $1.2B | $1.2B | $1.5B | |
| Levered Free Cash Flow | -- | $24M | $145M | $18M | $95M | |
Get MBLY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MBLY
Sector
P/E ratio
--
16.92x
PEG ratio
0.00x
0.17x
P/B ratio
1.07x
1.42x
Price / LTM sales
6.93x
0.68x
Growth Metrics
MBLY
Sector
Revenue growth
83.26%
0.64%
Earnings growth
--
-1.02%
Revenue (5-year growth)
13.48%
3.61%
Earnings forecast
$0.10
$0.24
Profitability
MBLY
Sector
Profitability FY 2024
$741M
$456.7M
Return on invested capital
-22.64%
4.58%
Return on assets
-21.76%
2.72%
Return on equity
-22.64%
6.7%
Earnings Date
Last Earnings Date
Apr
24
Next Earnings Date
Jul
24
Estimated Next Earnings Date
Jul
24
Balance Sheet
MBLY
Sector
Total cash
$1.5B
$139.6M
Short term investments
--
$46.8M
Total assets
$12.6B
$1.4B
Long term debt
--
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
